Trial Details

COMPLETED
Basic Information
Clinical ID c1281
Identifier NCT02559713
Trial Title Postmarketing Vedolizumab Milk-Only Lactation Study in Lactating Women With Active Ulcerative Colitis or Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Colitis, Ulcerative|Crohn's Disease
Interventions DRUG: Vedolizumab
Participant Information
Sponsor Takeda
City Aurora
Country/Region United States
Enrollment Criteria
Sex Requirement FEMALE
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE4
Time Information
Start Date 2017-11-29
Primary Completion Date 2019-02-22
Completion Date 2019-02-22